Among 74 infants referred for stage 4–5 ROP, 24% were misdiagnosed and later identified as having different retinal conditions, including FEVR, Coats disease, incontinentia pigmenti, dyskeratosis congenita, CAPN5- and DOCK6-related retinopathies, or ocular toxoplasmosis. Imaging and genetic testing were decisive in preventing misdiagnosis.

Publication date: Available online 19 February 2026 Source: AJO International Author(s): Robert T. Moore, Abdullah Al-Ani, Corrina Azarcon, Shellina Kherani, Rajinder Nirwan, Geoff Williams, Amin Kherani

Publication date: Available online 19 February 2026 Source: Progress in Retinal and Eye Research Author(s): John E. Dowling, Frank S. Werblin, Samuel M. Wu

Publication date: Available online 20 February 2026 Source: Experimental Eye Research Author(s): Ying Lian, Wenjing Jiang, Zhen Fan, Jiachao Shen

Publication date: Available online 19 February 2026 Source: Experimental Eye Research Author(s): Shweta Suiwal, Tanja Stachon, Virendra Kumar, Fabian N. Fries, Shao-Lun Hsu, Shanhe Liu, Shuailin Li, Swarnali Kundu, Berthold Seitz, Maryam Amini, Nóra Szentmáry

.

Seasonal variations in axial length in myopic children with defocus incorporated multiple segments spectacle lenses combined with DIMSA and OK lenses

In this report, we provide a post-hoc pooled of all 68 pediatric subjects aged 3 to 17 years enrolled in the three Phase 3 MIRA trials.

Higher-order aberrations were corrected by around 75% in eyes with keratoconus fitted with Zenlens Chroma HOA, according to data presented at the Global Specialty Lens Symposium. “Patients with keratoconus absolutely gain the most [from higher-order aberration-correcting lenses], and that has everything to do with the back surface of their cornea,” Jason Jedlicka, OD, FAAO, FSLS, clinical professor and chief of cornea and contact lens service at Indiana University School of Optometry, told Healio. “It’s the posterior cornea that creates the [higher-order aberrations]

Eye, Published online: 19 February 2026; doi:10.1038/s41433-026-04323-5Infographic: effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the centre of the macula and good visual acuity (DRCR Protocol V Study)

Eye, Published online: 19 February 2026; doi:10.1038/s41433-026-04246-1Infographic: study design of the QUASAR randomised trial of aflibercept 8 mg in retinal vein occlusion

Eye, Published online: 19 February 2026; doi:10.1038/s41433-026-04312-8Peripheral vascular scorching with posterior pole ember glow—hyperacute outer retinal dysfunction

Eye, Published online: 19 February 2026; doi:10.1038/s41433-026-04315-5Vitreous seeding in metastatic cutaneous melanoma

Eye, Published online: 19 February 2026; doi:10.1038/s41433-026-04299-2Focal scleral nodule presenting as a depigmented lesion

Eye, Published online: 19 February 2026; doi:10.1038/s41433-026-04309-3Dropless cataract surgery: comparing sub-Tenon’s and topical steroids for postoperative inflammation prophylaxis

Eye, Published online: 19 February 2026; doi:10.1038/s41433-026-04331-5Differentiation of macular atrophy secondary to neovascular age-related macular degeneration vs. de novo geographic atrophy: a multimodal analysis

Eye, Published online: 19 February 2026; doi:10.1038/s41433-026-04303-9Correlation between blood glucose levels and endophthalmitis risk after intravitreal injections of anti-vascular endothelial growth factor

WAIKOLOA, Hawaii — In this expert perspective from Retina 2026, Murtaza K. Adam, MD, of Colorado Retina Associates, discusses real-world data coming in 2026. He said he is excited about data on Eylea HD (aflibercept 8 mg, Regeneron). Adam said there is already “robust” real-world data on Vabysmo (faricimab-svoa, Genentech) in neovascular age-related macular degeneration and diabetic macular edema, and “we are looking forward to seeing how the second-generation molecules altogether fare and compare to one another.”

Mission Statement: To be the indispensable source of ophthalmic knowledge by promptly publishing innovative, clinically relevant research through consistent and authoritative peer review and, thereby, to be the first choice of authors for their important manuscripts.

A 66-year-old man had nebulomacular corneal opacities, iris atrophy, and corectopia along with coarse facial skin, resorbed digits, anesthetic patches, and healed trophic skin ulcers. What would you do next?

This case report discusses a diagnosis of B-cell lymphoma mucosa-associated lymphoid tissue (MALT) in the conjunctiva of a young boy who presented with a painless, enlarging conjunctival mass.

This cohort study assesses patterns in medical school students who matched with ophthalmology residency programs from 2021 to 2023, according to candidates’ sex, race, and ethnicity.

This cohort study using data from the Sight Outcomes Research Collaborative (SOURCE) data repository assesses how intraocular pressure levels influence the decision to initiate or escalate glaucoma therapy in clinical practice.

This secondary analysis of the Mega Donna Mega (MDM) randomized clinical trial investigated if early longitudinal changes in proteomic profiles in extremely preterm infants are associated with the development of severe retinopathy of prematurity.

This case report describes a case of Peters anomaly with central corneal neovascularization diagnosed in a female toddler who presented with acute intracorneal hemorrhage in the right eye.